Vascular CaV1.2 channels in diabetes

Eric A Pereira da Silva1, Miguel Martín-Aragón Baudel1, Junyoung Hong1

  • 1Department of Pharmacology, University of California, Davis, CA, United States.

Current Topics in Membranes
|November 11, 2022
PubMed

Insights

Diabetic vasculopathy involves vascular smooth muscle dysfunction. Hyperglycemia alters L-type calcium channels (CaV1.2), contributing to diabetes-related vascular complications.

Area of Science:

  • Cardiovascular Biology
  • Endocrinology
  • Molecular Medicine

Background:

  • Diabetic vasculopathy is a major complication of diabetes, leading to significant morbidity and mortality.
  • Hyperglycemia, a hallmark of diabetes, contributes to vascular dysfunction, affecting both endothelial and vascular smooth muscle cells.
  • Emerging research highlights the role of vascular L-type calcium channels (CaV1.2) in hyperglycemia-induced vascular dysfunction.

Purpose of the Study:

  • To summarize the current understanding of vascular CaV1.2 channels in physiological and diabetic conditions.
  • To emphasize the role of CaV1.2 in vascular smooth muscle and its regulation by hyperglycemia.
  • To explore the mechanisms of CaV1.2 dysregulation in hyperglycemia and diabetes.

Main Methods:

  • Review of existing literature on CaV1.2 channel function in vascular smooth muscle.
  • Analysis of studies investigating the effects of elevated glucose on CaV1.2 channel activity.
  • Examination of molecular mechanisms underlying CaV1.2 dysregulation in diabetes.

Main Results:

  • Vascular smooth muscle is a key site for hyperglycemia-induced vascular dysfunction.
  • Elevated glucose levels directly impact the function of vascular CaV1.2 channels.
  • Specific mechanisms for CaV1.2 dysregulation in hyperglycemia and diabetes are being elucidated.

Conclusions:

  • CaV1.2 channels are implicated in the vascular complications of diabetes.
  • Understanding CaV1.2 regulation offers potential therapeutic targets for diabetic vasculopathy.
  • Further research is needed to fully elucidate CaV1.2 regulation in health and diabetes.